Results 211 to 220 of about 9,376,530 (330)

Biodegradable Zinc‐Based Alloys for Guided Bone Regeneration Membranes: Feasibility, Current Status, and Future Prospects

Advanced Science, EarlyView.
Recent research has shown that biodegradable metals based on zinc (Zn) may be used as guided bone regeneration (GBR) membrane materials. This study examines their viability from the standpoints of material science and biology, reports on the state of research on Zn‐based GBR membranes, and suggests specific development plans based on the potential and ...
Kai Chen, Ping Li, Qiang Guan, Xuenan Gu, Li Zhao, Linjun Huang, Chenyang Huang, Yu Qin, Chunhao Yu, Ting Zhang, Hejia Li, Yongcan Huang, Yufeng Zheng   +12 more
wiley   +1 more source

Outcomes of Ixazomib Treatment in Relapsed and Refractory Multiple Myeloma: Insights from Croatian Cooperative Group for Hematologic Diseases (KROHEM). [PDF]

Medicina (Kaunas)
Batinić J, Dreta B, Rinčić G, Mrdeža A, Jakobac KM, Krišto DR, Vujčić M, Piršić M, Jonjić Ž, Periša V, Sinčić Petričević J, Coha B, Holik H, Valković T, Stanić M, Krečak I, Stojanović A, Sajfert D, Bašić-Kinda S.   +18 more
europepmc   +1 more source

Lenvatinib Plus Paclitaxel as Second‐Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study

Advanced Science, EarlyView.
This study determines the maximum tolerated dose of lenvatinib in combination with paclitaxel as second‐line therapy for advanced gastric cancer patients. A dynamic network biomarker panel associated with patient prognosis and response to treatment is established.
Chenfei Zhou, Jinling Jiang, Liting Guo, Wenqi Xi, Junwei Wu, Qu Cai, Jun Ji, Feng Qi, Jun Zhang   +8 more
wiley   +1 more source

Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy

Blood Cancer Journal
Yujie Liu, Yuqing Tu, Jinyan Xiao, Yifan Shen, Biqi Zhou, Qiannan Yang, Lei Yu, Lijuan Qi, Jia Chen, Tianhui Liu, Depei Wu, Yang Xu   +11 more
doaj   +1 more source

Performance of Large Language Models in Diagnosing Rare Hematologic Diseases and the Impact of Their Diagnostic Outputs on Physicians: Combined Retrospective and Prospective Study.

J Med Internet Res
Yu H, Chen T, Zhang X, Yang Y, Liu Q, Yang C, Shen K, Li H, Tang W, Zhong X, Shuai X, Yu X, Liao Y, Wang C, Zhu H, Wu Y.   +15 more
europepmc   +1 more source

Editorial: Practical recommendations and consensus for the management of immune mediated hematologic diseases. [PDF]

Front Immunol
Fattizzo B, Berentsen S, Barcellini W.
europepmc   +1 more source

The Performance of (1, 3)-^|^beta;-D-glucan and Aspergillus Galactomannan Measurement for Early Diagnosis of Invasive Aspergillosis in Patients with Hematological Diseases

, 2004
Yuji Horiguchi
openalex   +2 more sources

Endothelialized microfluidics for studying microvascular interactions in hematologic diseases.

Journal of Visualized Experiments, 2012
D. Myers, Y. Sakurai, Reginald Tran, Byungwook Ahn, E. Hardy, R. Mannino, Ashley Kita, Michelle Tsai, W. Lam   +8 more
semanticscholar   +1 more source

Senescence‐Inducing Therapy Sequential NIR‐II Mild Photothermal/Senolytic Therapy of Triple Negative Breast Cancer

Advanced Science, EarlyView.
Targeting triple‐negative breast cancer remains challenging due to limited therapies and drug resistance. A sequential theranostic strategy combining palbociclib‐induced senescence (enhancing heat sensitivity via HSP70 downregulation) with an NIR‐II nanoplatform (IQ NPs) for mild photothermal therapy (PTT) and quercetin‐mediated senolysis is developed.
Liya Yu, Yehui Kang, Mengdie Yu, Yuejia Ding, Yang Chen, Qingyuan Wu, Yu Cai, Huiyu Liu, Zhenye Lv   +8 more
wiley   +1 more source

Obinutuzumab in Combination with Alternative Chlorambucil Schedules in Front-Line Treatment of Chronic Lymphocytic Leukemia: A Study by KroHem, the Croatian Cooperative Group for Hematologic Diseases. [PDF]

Biomedicines
Aurer I, Jakšić O, Bašić-Kinda S, Mišura-Jakobac K, Sinčić-Petričević J, Novaković-Coha S, Galušić D, Holik H, Valković T, Županić-Krmek D, Hude-Dragičević I, Milunović V, Pejša V.   +12 more
europepmc   +1 more source